Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS safety_alert · 2026-04-08Clinical Trial Update: Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside [NA]
A clinical trial update outlining vascular toxicities observed with immune checkpoint inhibitors, highlighting safety signals and implicatio…
-
CLINICAL_TRIALS safety_alert · 2024-05-29Clinical Trial Update: Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients
This post-marketing surveillance update assesses the safety of Cabometyx in Korean patients with Renal Cell Carcinoma, Hepatocellular Carcin…
-
CLINICAL_TRIALS safety_alert · 2017-05-31Clinical Trial Update: Interleukin-2-Induced Cognitive/Affective/Sleep Symptoms
A clinical trial update notes cognitive, affective, and sleep symptoms linked to high-dose interleukin-2. The conditions involved are metast…
-
CLINICAL_TRIALS safety_alert · 2014-04-21Clinical Trial Update: Hepatic Monitoring for Pazopanib
Safety update on Pazopanib for renal cell carcinoma focusing on hepatic monitoring requirements. The document outlines liver function monito…
-
CLINICAL_TRIALS safety_alert · 2013-07-04Clinical Trial Update: Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients
This post-marketing surveillance study evaluated the safety and tolerability of Sunitinib Malate (Sutent) in Filipino patients with metastat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.